Palantir appears to be the ‘new Nvidia’. Should I buy the stock for my ISA?

AI stock Palantir is generating enormous returns for investors at the moment. Should Edward Sheldon buy it for his Stocks and Shares ISA?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Young black man looking at phone while on the London Overground

Image source: Getty Images

Palantir (NASDAQ: PLTR) is one of the hottest stocks in the market right now. In recent months, it seems to have replaced Nvidia as the artificial intelligence (AI) stock to own.

I’ve had this tech stock on my watchlist for a while now, but I’ve never actually bought it for my ISA. Is now the time to pull the trigger?

The real deal

Palantir’s recent results have been really impressive. In my view, they’ve shown that this software company’s the real deal when it comes to AI.

Take the company’s Q4 2024 results, for example. For the period, revenue was up 36% year on year to $828m. Meanwhile, US commercial revenue was up a huge 64% to $214m. Clearly, demand for the company’s AI solutions (which help organisations use their data to get an edge) is sky-high right now.

What has really struck me is the confident tone from management.

Our business results continue to astound, demonstrating our deepening position at the centre of the AI revolution,” wrote CEO Alex Karp in the Q4 results. “We are still in the earliest stages, the beginning of the first act, of a revolution that will play out over years and decades,” he said in the letter to shareholders.

I like this confidence and the bullish long-term outlook. Overall, this company looks really exciting to me. I genuinely think it could be one of the major beneficiaries of the AI revolution.

I’m struggling with the valuation

However, there are a couple of issues that concern me from an investment perspective right now.

One is the stock’s recent move higher. Over the last year, it’s risen about 350% (which makes Nvidia’s 85% gain look pedestrian). I’m always hesitant to buy a stock after that kind of move because a pullback is often on the horizon.

Another is the valuation. Currently, Palantir has a market-cap of $256bn. Yet this year it’s only forecast to achieve $3.7bn in sales. So the price-to-sales ratio’s 69, which is worryingly high (for reference Nvidia’s on about 17).

As for the price-to-earnings (P/E) ratio, that’s currently about 205. That’s also very high (for Nvidia, read 30).

Now I’m not afraid to invest in high-valuation companies. Currently, I own quite a few high-multiple growth stocks. But for me, Palantir’s multiples are too much of a stretch. I think buying here would be risky.

If revenue growth in the next few quarters was to come in below expectations for some reason (eg fewer new deals signed with government agencies or corporations), this stock could get crushed. It’s worth noting here that the average broker price target at present is $86 – about 24% below the current share price.

My move now

Given the high valuation, I’m going to leave Palantir on my watchlist for now. After a 350% gain over the last 12 months, I’m not going to chase the stock.

If we were to see a sizeable pullback however, I could be interested in taking a small position as a speculative long-term investment. As I said above, I think this company’s the real deal when it comes to AI.

Edward Sheldon has positions in Nvidia. The Motley Fool UK has recommended Nvidia. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »